With 1,190 fresh cases, Indias COVID-19 tally has gone up to 4,46,55,828, while the number of active cases of the infection has declined to 16,243, the Union health ministry said on Wednesday. The death toll due to the viral disease has climbed to 5,30,452 with 1,375 more fatalities, including 1,369 deaths reconciled by Punjab and two reconciled by Kerala, according to the ministrys data updated […]
The agreed purchase consideration for the acquisition of 99.92% shareholding of KIFTPL from its shareholders is Rs156 crore.
The frontline indices continued to trade with modest losses in the early afternoon trade. The Nifty traded below the 18,100 level. Media, pharma and metal stocks advanced while auto, PSU bank and IT stocks declined. At 12:30 IST, the barometer index, the S&P BSE Sensex, was down 206.15 points or 0.34% to 60,915.20. The Nifty 50 index gained 60.10 points or 0.33% to 18,085.30. In […]
Alembic Pharmaceuticals advanced 6.22% to Rs 614.45 after the drug maker received final approval from the US Food & Drug Administration (USFDA) for its abbreviated new drug application (ANDA) for Mesalamine extended-release capsules.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132 (Member ID - NSE: 10975 BSE: 179 MCX: 55995 NCDEX: 01249), DP SEBI Reg. No. IN-DP-185-2016, IA SEBI Regn. No: INA000000623, Merchant Banker SEBI Regn. No. INM000010940, RA SEBI Regn. No: INH000000248, BSE Enlistment Number (RA): 5016, AMFI-Registered Mutual Fund Distributor & SIF Distributor
ARN NO : 47791 (Date of initial registration – 17/02/2007; Current validity of ARN – 08/02/2027), PFRDA Reg. No. PoP 20092018, IRDAI Corporate Agent (Composite) : CA1099
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
